Civet Pharmaceuticals Private Limited
About Civet Pharmaceuticals Private Limited
Data last updated:
Civet Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 15 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51397BR2010PTC015315. Its GSTIN is 10AADCC8989J1ZB (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Brajesh Kumar and Amrita Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Patna, Bihar.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.89 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹3,245 (net margin -0.4%) and EBITDA of ₹14,526 (EBITDA margin 1.8%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 19% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Civet Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH/O Brajesh Kumar Rastriya Pustkalaya Lane East Lohanipur, Kadamkuan, Patna, Bihar, India – 800003
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Civet Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Civet Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Civet Pharmaceuticals Private Limited, buy the company report.
Financials of Civet Pharmaceuticals Private Limited
FY 2023 filings availableCivet Pharmaceuticals Private Limited reported revenue of ₹7.89 Lakh (down 27% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 27% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,526 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,245 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Civet Pharmaceuticals Private Limited, buy the company report.
Board of directors of Civet Pharmaceuticals Private Limited
Civet Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brajesh Kumar | Director | 26 Mar 2022 | 4 Years 7 Months | Current |
| Amrita Kumari | Director | 15 Feb 2010 | 16 Years 8 Months | Current |
Peer comparison
Civet Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avant Pharmaceuticals Private Limited | ₹7.91 Lakh (FY 2025) | -90.0% | New Delhi, Delhi, India | |||
| N. S. Pharmaceuticals Private Limited | ₹7.9 Lakh (FY 2025) | 7.0% | Jarmundi, Jharkhand, India | |||
| Civet Pharmaceuticals Private Limitedthis company | ₹7.89 Lakh (FY 2023) | -₹3,245 | -0.4% | -27.0% | Patna, Bihar, India | |
| Nayasa Life Science Private Limited | ₹7.85 Lakh (FY 2025) | -87.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Civet Pharmaceuticals Private Limited, buy the company report.
Auditor
Civet Pharmaceuticals Private Limited is audited by ARVIND ARPAN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARVIND ARPAN & ASSOCIATES | FY 2017 | 010011C |
Shareholding
The shareholding of Civet Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Civet Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Civet Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Civet Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Civet Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCC8989J1ZB | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Civet Pharmaceuticals Private Limited, buy the company report.
Recent activity
Civet Pharmaceuticals Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Brajesh Kumar was appointed as Director on 26 Mar 2022.
Frequently asked questions
Civet Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 15 February 2010 (16+ years old) and is registered under CIN U51397BR2010PTC015315.
Civet Pharmaceuticals has 2 current directors:
- Brajesh Kumar - Director
- Amrita Kumari - Director
The latest financial statements of Civet Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Civet Pharmaceuticals is 10AADCC8989J1ZB, registered in Bihar.
The CIN (Corporate Identification Number) of Civet Pharmaceuticals is U51397BR2010PTC015315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Civet Pharmaceuticals was incorporated on 15 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Civet Pharmaceuticals by revenue are Avant Pharmaceuticals Private Limited, N. S. Pharmaceuticals Private Limited, Nayasa Life Science Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Brajesh Kumar was appointed as Director on 26 Mar 2022. Chandeshwar Prasad ceased to be Managing Director on 26 Mar 2022. Amrita Kumari was appointed as Director on 15 Feb 2010.
The registered office of Civet Pharmaceuticals is at HO Brajesh Kumar Rastriya Pustkalaya Lane East Lohanipur, Kadamkuan, Patna, Bihar, India – 800003.
Civet Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Civet Pharmaceuticals is compliant as of 09 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
